Long COVID Patients Benefit from Cognitive Therapy
Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.
Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.
Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.
Read MoreMonitoring sleep quality could help healthcare providers identify respiratory issues in ALS patients before they become advanced.
Read MoreResearchers found that sialidase inhibitors—a class of flu drugs including oseltamivir (Tamiflu)—protected against degradation of protective sugar molecules tied to cognitive decline and premature aging in people living with HIV.
Read MoreSmoking cessation improves long-term brain health, provided individuals maintain a stable weight following the transition.
Read MorePoor sleep is associated with increased tau protein accumulation and memory issues specifically in women with a higher genetic predisposition to Alzheimer’s disease.
Read MoreImplementing specific protocols for older surgical patients can reduce complications such as delirium, falls, and pneumonia.
Read MoreDegeneration in the locus coeruleus, alongside the hypothalamus, contributes to sleepiness and muscle weakness in narcolepsy type 1.
Read MoreNew research suggests environmental air quality including air pollution plays a significant role in triggering migraine episodes.
Read MoreA clinical trial found that fluvoxamine significantly improved fatigue and quality of life for Long COVID patients with persistent symptoms.
Read MoreCurrently smoking is associated with a lower risk of developing Parkinson’s disease, but quitting smoking was associated with a lower risk of death.
Read MoreNewborns who receive surgery for a severe form of spina bifida are more likely to suffer from breathing disruptions during sleep than previously known.
Read MorePatients with neurocognitive difficulties post COVID-19 infection displayed a significant increase in their blood plasma of a crucial protein linked to neurodegenerative diseases and found in many Alzheimer’s patients.
Read MoreHHS secretary Robert F. Kennedy Jr approved the addition of duchenne muscular dystrophy and metachromatic leukodystrophy to the Recommended Uniform Screening Panel (RUSP).
Read MoreComorbid insomnia and sleep apnea (COMISA) was significantly associated with worse verbal memory outcomes in women, but not in men.
Read MoreResearchers analyzed health records from nearly 2 million patients and discovered higher dementia risk for patients with insomnia, depression, and both depression and insomnia.
Read MoreTargeting and restoring circadian rhythms in specific brain cells could offer a novel approach to slowing or preventing Alzheimer’s progression.
Read MoreDaytime sleepiness is a symptom of sleep deficiency that affects up to 20% of adults and may increase the risk of perioperative neurocognitive disorders (PNDs).
Read MoreInfluenza-associated acute necrotizing encephalopathy carries a high morbidity and mortality rate among children but flu vaccination, early detection, and a standardized treatment approach may prevent the condition.
Read MorePeople with schizophrenia have higher rates of tobacco smoking, however, higher COPD prevalence remained after adjusting for smoking, suggesting that the link may also be syndemic.
Read MoreInfluenza—not the flu antiviral oseltamivir (Tamiflu)—is associated with neuropsychiatric events in children, according to research published in JAMA Neurology.
Read MoreChlamydia pneumoniae and SARS-CoV-2 infections may play a role in the pathogenesis of Alzheimer’s disease.
Read MoreA new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer’s disease.
Read MoreScientists suggest sleep plays a role in boosting insight and the ability to experience “eureka” moments.
Read MoreAntidepressants that suppress REM sleep are associated with improved survival in people with amyotrophic lateral sclerosis (ALS), according to research at ATS 2025.
Read More